You cited Sept 2020 that was six months into the COVID hype train and the 10s of millions in volume + the surge to $0.60 on RBL data. Go back another 9 months. You'll see roughly the figured I referenced. I can't load EDGAR right now.
We were engaging Locust Walk (a second time?) for a deal before the hopeful COVID hype started. We were probably looking at a buyout or licensing deal with terms similar to B-UP just scaled up a few times for B-OM. It wasn't going to be good. Just like it won't be good if we have to return to that avenue.